VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,676 | -62.2% | 499 | -1.0% | 0.00% | – |
| Q2 2023 | $12,363 | -7.9% | 504 | -12.7% | 0.00% | – |
| Q1 2023 | $13,427 | +5207.1% | 577 | +5670.0% | 0.00% | – |
| Q4 2022 | $253 | – | 10 | -41.2% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 17 | -26.1% | 0.00% | – |
| Q2 2022 | $1,000 | – | 23 | +130.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 10 | -81.5% | 0.00% | – |
| Q4 2021 | $2,000 | -99.8% | 54 | -99.7% | 0.00% | -100.0% |
| Q3 2021 | $904,000 | -38.6% | 20,779 | -33.3% | 0.04% | -41.9% |
| Q2 2021 | $1,473,000 | +226.6% | 31,162 | +254.2% | 0.06% | +195.2% |
| Q1 2021 | $451,000 | +23.9% | 8,798 | -35.2% | 0.02% | +5.0% |
| Q4 2020 | $364,000 | -21.9% | 13,585 | 0.0% | 0.02% | -31.0% |
| Q3 2020 | $466,000 | +983.7% | 13,585 | +1185.2% | 0.03% | +866.7% |
| Q2 2020 | $43,000 | – | 1,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |